Cover Image
市場調查報告書

一鹼多型(SNP)遺傳基因型判定:技術及全球市場

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

出版商 BCC Research 商品編碼 314718
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
一鹼多型(SNP)遺傳基因型判定:技術及全球市場 Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
出版日期: 2014年09月24日 內容資訊: 英文 124 Pages
簡介

一鹼多型(SNP)遺傳基因型判定的全球市場規模在2013年為35億美元。這個市場預測從2014年到2019年這5年將以21.9%的年複合成長率(CAGR)持續擴大,到2019年預測市場規模將達到115億美元。

本報告詳細調查SNP遺傳基因型判定的全球市場,提供各種技術,用途,市場動態,市場趨勢,詳細分析市場競爭情形,現在的市場分析與今後的市場預測。

第1章 序論

第2章 摘要整理

  • 到2019年前的SNP遺傳基因型判定全球市場規模

第3章 市場概要

  • 序論
  • 市場分析
  • 用於突然變異分析的SNP
  • SNP定義
    • SNP的研究方法
    • SNP的類別
    • SNP的用途
  • 市場動態
    • 推動市場成長要素
    • 阻礙市場成長要素
  • 各地區市場魅力
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區
  • 市場競爭情形
  • 技術創新和目前趨勢
  • 公共及私人資金
  • 主要企業的市場佔有率
  • 專利分析
  • 建議
    • 廣泛的研究開發投資
    • 獲得外部的投資資金來源
  • 結論

第4章 各技術SNP遺傳基因型判定的全球市場

  • 概要
  • 微陣列與基因芯片的SNP遺傳基因型判定

第5章 各用途SNP遺傳基因型判定市場

  • 概要
  • 植物的改良
  • 動物的遺傳應用
  • 製藥及基因藥理學
  • 診斷研究
  • 農業用生物技術

第6章 各地區SNP遺傳基因型判定市場

  • 概要
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第7章 市場競爭情形

第8章 企業簡介

第9章 專利分析

目錄
Product Code: BIO139A

REPORT HIGHLIGHTS

The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, a compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.

This report provides:

  • An overview of the global markets for single nucleotide polymorphism genotyping.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • A geographic breakdown into the regions of North America, Europe, Asia-Pacific (APAC), and the rest of the world.
  • Information on the market's dynamics as well as innovations and current trends.
  • Analysis of the regulatory environment and its impact.
  • Evaluation of market drivers, restraints, and opportunities.
  • Relevant patent analysis.

SCOPE OF THE REPORT

This research report incorporates an in-depth analysis of the SNP genotyping market, including market estimations and trends through 2019. Major players, competitive intelligence, technologies, applications, market dynamics and geographic opportunities are discussed in detail in the report. The report discusses recent developments and the product portfolios of the major players. Patent analysis in the report focuses on providing technological trends across the last few years in regions such as the U.S., Europe and Japan. The report presents market analysis and estimates CAGR (compound annual growth rate) for SNP genotyping technologies and geographies.

ANALYST'S CREDENTIALS

Vijay Laxmi has more than 20 years of domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and has handled projects for various consultancies. She has authored market research studies in the healthcare domain.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • TITLE DESCRIPTION
  • SCOPE OF THE REPORT
  • MARKET STRUCTURE
  • INTENDED AUDIENCE
  • RESEARCH METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR SNP GENOTYPING, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR SNP GENOTYPING, 2013-2019 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • INTRODUCTION
  • MARKET ANALYSIS
  • SNP FOR MUTATIONAL ANALYSIS
  • SNP DEFINITION
    • METHODS OF STUDYING SNPS
    • CLASSIFICATION OF SNPS:
    • USES OF SNPS:
  • MARKET DYNAMICS
    • DRIVERS
      • Decreasing Prices of DNA Sequencing
        • FIGURE 1: AVERAGE PRICE YOY TRENDS OF A GENOME, 2003-2012 ($)
      • Growing Global Prevalence of Cardiovascular Disease, Diabetes and Cancer Triggering Demand for Developing Alternative and Relatively More Permanent Therapeutic Solutions
        • FIGURE 2: PROJECTED PREVALENCE OF DIABETES, BY REGION, 2035 (% INCREASE OVER 2013)
      • Growing Demand for Personalized Medicine and Growing Importance of SNP Genotyping in the Drug Development Process
        • TABLE 1: USE OF SNP GENOTYPING DURING ALL THE STAGES OF DRUG DEVELOPMENT
      • Increasing Demand for Genome Analysis in Animal and Plant Livestock
    • RESTRAINTS
      • Lack of Appropriate Reimbursement Policies
  • MARKET ATTRACTIVENESS BY REGION
    • NORTH AMERICA
      • TABLE 2: LIST OF KEY ORGANIZATIONS FUNDING GENOMICS RELATED R &D INITIATIVES IN THE U.S.
      • FIGURE 3: COUNTRY OF ORIGIN OF PUBLICLY TRADED GENOMICS FIRMS (%)
    • EUROPE
    • ASIA-PACIFIC
    • REST OF THE WORLD (ROW)
  • COMPETITIVE LANDSCAPE
  • INNOVATIONS AND CURRENT TRENDS
  • PUBLIC AND PRIVATE FUNDING
    • TABLE 3: MAJOR PRIVATE AND PUBLIC FUNDING ORGANIZATIONS
  • MARKET SHARE OF KEY PLAYERS
    • FIGURE 4: COMPANY MARKET SHARE, 2013 (%)
  • PATENT ANALYSIS
  • RECOMMENDATIONS
    • EXTENSIVE R&D INVESTMENTS
    • ACQUIRING EXTERNAL FUNDING
  • CONCLUSION

CHAPTER 4 - GLOBAL SNP GENOTYPING MARKET BY TECHNOLOGY

  • OVERVIEW
    • TABLE 4: SNP GENOTYPING MARKET, BY TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
  • SNP GENOTYPING BY MICROARRAYS AND GENECHIPS
    • ILLUMINA
    • AFFYMETRIX
    • FLUIDIGM
      • TABLE 5: MICROARRAYS AND GENECHIPS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • SEQUENOM MASSARRAY MALDI-TOF
      • TABLE 6: SEQUENOM MASSARRAY MALDI-TOF MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • SNP PYROSEQUENCING
      • TABLE 7: SNP PYROSEQUENCING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • APPLIED BIOSYSTEMS SNPLEX
      • TABLE 8: APPLIED BIOSYSTEMS SNPLEX MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TAQMAN ALLELIC DISCRIMINATION
      • TABLE 9: TAQMAN ALLELIC DISCRIMINATION MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • OTHER SNP GENOTYPING TECHNOLOGIES
      • TABLE 10: OTHER SNP GENOTYPING TECHNOLOGIES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)

CHAPTER 5 - SNP GENOTYPING MARKET BY APPLICATIONS

  • OVERVIEW
    • TABLE 11 GLOBAL SNP GENOTYPING MARKET BY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • PLANT IMPROVEMENT
    • SNPS ARE IMPORTANT FOR INCREASING CROP YIELD
      • TABLE 12: GLOBAL PLANT IMPROVEMNT MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • ANIMAL GENETICS
    • REDUCING COST OF SEQUENCING
    • IMPACT OF GENOMIC SELECTION IN ANIMALS
    • IMPLEMENTATION OF GENOMIC SELECTION
    • TRENDS
    • NEXT WAVE OF DISCOVERIES AND NEW APPROACHES
    • OPPORTUNITIES FOR DEVELOPING COUNTRIES
    • COST EFFECTIVENESS IN SEQUENCING WILL HELP FURTHER RESEARCH IN ANIMALS
      • TABLE 13: GLOBAL ANIMAL GENETICS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • PHARMACEUTICALS AND PHARMACOGENOMICS
    • LINKAGE AND ASSOCIATION STUDIES
    • PHARMACEUTICAL APPLICATIONS
    • SNP ARRAYS ARE USEFUL TOOLS FOR THE KNOW-HOW OF EVEN SLIGHT DIFFERENCES AMONG WHOLE GENOMES
    • CONCLUSIONS
      • TABLE 14: GLOBAL PHARMACEUTICALS AND PHARMACOGENOMICS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • DIAGNOSTIC RESEARCH
    • GENETIC RISK FACTORS
      • TABLE 15: GLOBAL DIAGNOSTICS RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • AGRICULTURAL BIOTECHNOLOGY
    • CASE STUDY
    • CONCLUSION
      • TABLE 16: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • AQUACULTURE
      • TABLE 17: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • OTHERS (HUMAN IDENTITY TESTING, HUMAN FORENSICS, CONSERVATION)
      • TABLE 18: GLOBAL OTHERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)

CHAPTER 6 - SNP GENOTYPING MARKET BY REGION

  • OVERVIEW
    • NORTH AMERICA
      • TABLE 19: NORTH AMERICA SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • EUROPE
      • TABLE 20: EUROPE SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • ASIA-PACIFIC
      • TABLE 21 ASIA-PACFIC SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • REST OF WORLD (ROW)
      • TABLE 22: ROW SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)

CHAPTER 7 - COMPETITIVE LANDSCAPE

  • FIGURE 5: STRATEGIES FOLLOWED IN THE SNP GENOTYPING MARKET BY KEY PLAYERS, 2011 TO APRIL 2014 (NUMBER)
  • TABLE 23: PRODUCT LAUNCHES IN SNP GENOTYPING MARKET, 2011-APRIL 2014
  • TABLE 24: JOINT VENTURES/ACQUISITIONS/AGREEMENTS IN THE SNP GENOTYPING MARKET, 2011-APRIL 2014
  • TABLE 25: CERTIFICATION AND RESEARCH & DEVELOPMENT IN SNP GENOTYPING MARKET, 2011-APRIL 2014
  • TABLE 26: EXPANSION/REORGANIZATION/OTHERS IN SNP GENOTYPING MARKET, 2011-APRIL 2014

CHAPTER 8 - COMPANY PROFILES

  • AFFYMETRIX INC.
    • TABLE 27: PRODUCT PORTFOLIO
    • TABLE 28: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • AGILENT TECHNOLOGIES
    • TABLE 29: PRODUCT PORTFOLIO
    • TABLE 30: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • BECKMAN COULTER
    • TABLE 31: PRODUCT PORTFOLIO
    • TABLE 32: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • BIODISCOVERY
    • TABLE 33: PRODUCT PORTFOLIO
    • TABLE 34: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • BIO-RAD LABORATORIES
    • TABLE 35: PRODUCT PORTFOLIO
    • TABLE 36: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • COMBIMATRIX
    • TABLE 37: PRODUCT PORTFOLIO
    • TABLE 38: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • DOUGLAS SCIENTIFIC
    • TABLE 39: PRODUCT PORTFOLIO
    • TABLE 40: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • ENZO LIFE SCIENCES
    • TABLE 41: PRODUCT PORTFOLIO
    • TABLE 42: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • EPIGENDX
    • TABLE 43: PRODUCT PORTFOLIO
    • TABLE 44: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • FLUIDIGM CORP.
    • TABLE 45: PRODUCT PORTFOLIO
    • TABLE 46: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • GE HEALTHCARE
    • TABLE 47: PRODUCT PORTFOLIO
    • TABLE 48: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • ILLUMINA INC.
    • TABLE 49: PRODUCT PORTFOLIO
    • TABLE 50: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • LI-COR BIOSCIENCES
    • TABLE 51: PRODUCT PORTFOLIO
    • TABLE 52: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • LIFE TECHNOLOGIES (A BRAND OF THERMO FISHER SCIENTIFIC)
    • TABLE 53: PRODUCT PORTFOLIO
    • TABLE 54: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • OCIMUM BIOSOLUTIONS
    • TABLE 55: PRODUCT PORTFOLIO
    • TABLE 56: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • PREMIER BIOSOFT
    • TABLE 57: PRODUCT PORTFOLIO
    • TABLE 58: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • QIAGEN
    • TABLE 59: PRODUCT PORTFOLIO
    • TABLE 60: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • ROCHE
    • TABLE 61: PRODUCT PORTFOLIO
    • TABLE 62: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • SEQUENOM INC.
    • TABLE 63: PRODUCT PORTFOLIO
    • TABLE 64: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
  • SIGMA-ALDRICH
    • TABLE 65: PRODUCT PORTFOLIO
    • TABLE 66: RECENT DEVELOPMENTS, 2011 TO APRIL 2014

CHAPTER 9 - PATENT ANALYSIS

  • FIGURE 6: PATENTS BY REGION, 2011-JUNE 2014 (NUMBER)
  • TABLE 67: U.S. PATENTS, 2011-JUNE 2014
  • TABLE 68: EUROPEAN PATENTS, 2011-JUNE 2014
  • TABLE 69: JAPANESE PATENTS, 2011-JUNE 2014

LIST OF TABLES

  • SUMMARY TABLE GLOBAL MARKET FOR SNP GENOTYPING, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: USE OF SNP GENOTYPING DURING ALL THE STAGES OF DRUG DEVELOPMENT
    • TABLE 2: LIST OF KEY ORGANIZATIONS FUNDING GENOMICS RELATED R &D INITIATIVES IN THE U.S.
    • TABLE 3: MAJOR PRIVATE AND PUBLIC FUNDING ORGANIZATIONS
    • TABLE 4: SNP GENOTYPING MARKET, BY TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 5: MICROARRAYS AND GENECHIPS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 6: SEQUENOM MASSARRAY MALDI-TOF MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 7: SNP PYROSEQUENCING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 8: APPLIED BIOSYSTEMS SNPLEX MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 9: TAQMAN ALLELIC DISCRIMINATION MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 10: OTHER SNP GENOTYPING TECHNOLOGIES MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 11: GLOBAL SNP GENOTYPING MARKET BY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 12: GLOBAL PLANT IMPROVEMNT MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 13: GLOBAL ANIMAL GENETICS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 14: GLOBAL PHARMACEUTICALS AND PHARMACOGENOMICS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 15: GLOBAL DIAGNOSTICS RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 16: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 18: GLOBAL OTHERS MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 19: NORTH AMERICA SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: EUROPE SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: ASIA-PACFIC SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • TABLE 22: ROW SNP GENOTYPING TECHNOLOGIES MARKET, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: PRODUCT LAUNCHES IN SNP GENOTYPING MARKET, 2011-APRIL 2014
    • TABLE 24: JOINT VENTURES/ACQUISITIONS/AGREEMENTS IN THE SNP GENOTYPING MARKET, 2011-APRIL 2014
    • TABLE 25: CERTIFICATION AND RESEARCH & DEVELOPMENT IN SNP GENOTYPING MARKET, 2011-APRIL 2014
    • TABLE 26: EXPANSION/REORGANIZATION/OTHERS IN SNP GENOTYPING MARKET, 2011-APRIL 2014
    • TABLE 27: PRODUCT PORTFOLIO
    • TABLE 28: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 29: PRODUCT PORTFOLIO
    • TABLE 30: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 31: PRODUCT PORTFOLIO
    • TABLE 32: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 33: PRODUCT PORTFOLIO
    • TABLE 34: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 35: PRODUCT PORTFOLIO
    • TABLE 36: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 37: PRODUCT PORTFOLIO
    • TABLE 38: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 39: PRODUCT PORTFOLIO
    • TABLE 40: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 41: PRODUCT PORTFOLIO
    • TABLE 42: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 43: PRODUCT PORTFOLIO
    • TABLE 44: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 45: PRODUCT PORTFOLIO
    • TABLE 46: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 47: PRODUCT PORTFOLIO
    • TABLE 48: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 49: PRODUCT PORTFOLIO
    • TABLE 50: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 51: PRODUCT PORTFOLIO
    • TABLE 52: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 53: PRODUCT PORTFOLIO
    • TABLE 54: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 55: PRODUCT PORTFOLIO
    • TABLE 56: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 57: PRODUCT PORTFOLIO
    • TABLE 58: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 59: PRODUCT PORTFOLIO
    • TABLE 60: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 61: PRODUCT PORTFOLIO
    • TABLE 62: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 63: PRODUCT PORTFOLIO
    • TABLE 64: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 65: PRODUCT PORTFOLIO
    • TABLE 66: RECENT DEVELOPMENTS, 2011 TO APRIL 2014
    • TABLE 67: U.S. PATENTS, 2011-JUNE 2014
    • TABLE 68: EUROPEAN PATENTS, 2011-JUNE 2014
    • TABLE 69: JAPANESE PATENTS, 2011-JUNE 2014

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL MARKET FOR SNP GENOTYPING, 2013-2019 ($ MILLIONS)
    • FIGURE 1: AVERAGE PRICE YOY TRENDS OF A GENOME, 2003-2012 ($)
    • FIGURE 2: PROJECTED PREVALENCE OF DIABETES, BY REGION, 2035 (% INCREASE OVER 2013)
    • FIGURE 3: COUNTRY OF ORIGIN OF PUBLICLY TRADED GENOMICS FIRMS (%)
    • FIGURE 4: COMPANY MARKET SHARE, 2013 (%)
    • FIGURE 5: STRATEGIES FOLLOWED IN THE SNP GENOTYPING MARKET BY KEY PLAYERS, 2011 TO APRIL 2014 (NUMBER)
    • FIGURE 6: PATENTS BY REGION, 2011-JUNE 2014 (NUMBER)
Back to Top